Table 2.
Study | Duration | Patient Population | n | Dosage | Control Group | Outcome |
---|---|---|---|---|---|---|
Barbul et al. [59] | 14 days | Surgery | 36 | 24.8 g Arg | Not supplemented | ↑ Collagen deposition, ↑ Wound-breaking strength, ↑ Lymphocyte mitogenesis |
Nussbaum [64] | 14 days | Surgery | 30 | 17 g Arg | Not supplemented | ↑ Collagen synthesis, ↑ T-cell-mediated immune function, ↑ IGF-1 |
Debats et al. [65] | 5 days | Surgery | 35 | 30 g intravenous Arg | Isonitrogenous solution | Citrulline, ornithine and NO levels, Angiogenesis, Reepithelialisation |
Sigal et al. [66] | 7 days | Abdominal surgery | 30 | 14.7 g intravenous Arg | Isonitrogenous solution | Lymphocyte proliferation, NO |
Langkamp-Henken et al. [60] | 4 weeks | Elderly people with pressure ulcers | 33 | 0, 8.5 or 17 g Arg | Not supplemented | Lymphocyte proliferation, NO, IL-2 |
Arg: arginine; Cu: copper; Gln: glutamine; HBM: β-hydroxy-β-methylbutyrate; IGF-1: insulin-like growth factor; NO: nitric oxide; P: phosphorous; RME: resting metabolic expenditure; Zn: zinc; ↑: increases; does not increase or decrease.